Escitalopram for the treatment of major depression and anxiety disorders.
about
An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsIs escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials.Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells.Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.Effects of Escitalopram on Autonomic Function in Posttraumatic Stress Disorder Among Veterans of Operations Enduring Freedom and Iraqi Freedom (OEF/OIF).Efficacy and safety of escitalopram versus desvenlafaxine in the treatment of major depression: A preliminary 1-year prospective randomized open label comparative trial.Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety.Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population.The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials.Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study.Depressive episode with catatonic features in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).Escitalopram oxalate induces apoptosis in U-87MG cells and autophagy in GBM8401 cells.Bright light treatment for high-anxious young adults: a randomized controlled pilot study.Clinical features and efficacy of escitalopram treatment for geriatric depression.Efficacy of escitalopram oxalate for patients with post-stroke depression.
P2860
Q27491346-E0C8F140-3D44-4A8C-923E-63DB22F7BA40Q28305100-A12857D6-9D97-46EE-8F85-E232AE693229Q30493395-191EC1F4-EC9C-4BD0-BE0E-860F318AF3ACQ33899055-B031FAE0-BD1D-4E5F-83F7-52D8ED7CD566Q35057288-B3269066-D2ED-4337-B2E1-FE8EF659B02DQ35776730-6DA76BA1-417E-4FA2-9E2E-76187A00DBD3Q36606752-4517E034-DA39-454D-91E0-AB3856BBCB4CQ37329171-0FE747A5-4BF6-45B7-B2E7-D4E29E73C5B9Q37661849-A7D5A947-702A-438B-AD61-FEFDC51893A0Q38167693-BF5BBB88-DE4D-4E9B-A18A-CB576B3AB490Q40665191-D0ABDABA-F3B7-4FFB-A8AB-2FDE83A6BB06Q43246541-39714804-3090-4C0B-8E33-DB6AB57B8F21Q46006864-232D298C-B43B-4493-9A93-12F0D3E8FE77Q47985758-F6C0F0B5-64F6-4277-BF8A-55C03E32B18AQ48320515-6B36AC5A-2099-4A5B-948D-1DD2CFAECE90Q48799459-C87A1725-D7B4-498B-A75B-143B1B47F2C2Q53417601-93366C66-E24F-449E-B453-A7812C956573
P2860
Escitalopram for the treatment of major depression and anxiety disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Escitalopram for the treatment of major depression and anxiety disorders.
@en
Escitalopram for the treatment of major depression and anxiety disorders.
@nl
type
label
Escitalopram for the treatment of major depression and anxiety disorders.
@en
Escitalopram for the treatment of major depression and anxiety disorders.
@nl
prefLabel
Escitalopram for the treatment of major depression and anxiety disorders.
@en
Escitalopram for the treatment of major depression and anxiety disorders.
@nl
P2860
P356
P1476
Escitalopram for the treatment of major depression and anxiety disorders.
@en
P2093
Cyril Höschl
Jaromír Svestka
P2860
P304
P356
10.1586/14737175.8.4.537
P577
2008-04-01T00:00:00Z